David Pai, M.D.

David Pai, M.D.
Address:

2218 Kausen Dr., Suite 130
Elk Grove, CA 95758
Ph: 916-683-8774
Fax: 916-683-8777

Education:
  • University of Massachusetts
    Medical School Fellowship in Nephrology Worcester, MA
    July 2005 - June 2007
  • University of Massachusetts Medical School Chief Resident,
    Internal Medicine Residency Program Worcester, MA
    July 2004 - June 2005
  • University of Massachusetts Medical School Categorical,
    Internal Medicine Residency Program Worcester, MA
    July 2001 - June 2004
  • St. George's University School of Medicine
    Medical Doctorate Degree Grenada, WI / Bay Shore, NY
    August 1997 - June 2001
  • University of California, Los Angeles
    Bachelor of Science Psychology Los Angeles, CA
    Sept 1991 - June 1995
Certifications / Licensure / Work Experience:
  • American Board of Internal Medicine,
    Board Eligible in Nephrology
    July 2007
  • American Board of Internal Medicine Certification
    August 2005 - Devember 2015
  • Massachusetts Medical Licensure
    March 2005 - 2007
  • California Licensure
    2006
Professional Societies:
  • National Kidney Foundation
    2006 - Present
  • American Society of Nephrology
    2006 - Present
  • Renal Physicians Associations
    2006 - Present
  • Massachusetts Medical Society,
    Resident Physicians Fellowship appointed Communications Committee Representative
    2003 - 2004
  • Massachusetts Medical Society
    2001 - Present
  • American College of Physicians, American Society of Internal Medicine
    2001 - Present
Teaching Experience:
  • University of Massachusetts Medical School
    3rd Year Medical Student Renal Lecture Series: Acute Renal Failure
    2006 - 2007
  • University of Massachusetts Graduate School of Nursing,
    Worcester, MA Renal Lecure Series: Acute Renal Failure
    2006 - 2007
  • University of Massachusetts Medical School,
    Dept. of Medicine, Resident Noon Conference: Neflhrolithiasis
    August 2006
  • University of Massachusetts Medical School,
    Worcester, MA Clinical Instructor
    2005 - Present
  • University of Massachusetts Medical School, Worcester, MA Chief Resident Conducted Morning Reports and Noon Conferences Involved in Administrative Duties Within the Department of Medicine
    2005 - 2006
  • University of Massachusettes Medical School,
    Worecester, MA Physical Diagnosis Instructor for Second Year Medical Students
    2005 - 2006
Research:
  • Pleiotropic Effects of Starins in Patients with Hypertension and Microalbuminuria.
    Under John Danziger, M.D., Division of Renal Medicine.
    Massachusetts Medical Center, Worcester, MA (Under IRB Review)
    2006 - 2007
  • Study of Cox-2 Expression
    Division of Renal Medicine
    Brookdale University Hospital, Brooklyn, NY
    Performed Immunohistochemical Studies and Nephrectomies
    2000 - 2001
  • Lab Assistant / Researcher
    Division of Pediatric Hematology / Oncology
    University of California, Los Angeles Medical Center
    Studied Various Aspect of Ofn-Myc Expression in Neuroblastoma
    1992 - 1995
Publications:
  • Wada, RK; Pai, DS; Huang, J; Yamashiro, JM; Sidell, N: "Interferon-Gamma and Retinoic Acid Down Regulate N-myc in Neuroblastoma Through Complimentary Mechanism of Action" Cancer Letter 1997 Dec 23; 121(2):181-8
  • Goodman, LA; Lui, BC; Thiele, CJ; Schmidy, ML; Cohn, SL; Yamashiro, JM; Pai, DS; Ikegaki, N; Wada, RKl "Modulation of N-myc Expression Alters the Invasiveness of Neuroblastoma" Clinical Experimental Metastasis. 1997 Mar; 15(2) 130-9
  • Woodruff, KA; "Cell Type Specific Activity of the N-myc Promoter in the Human Neuroblastoma Cells is Mediated by a Down Stream Silencer" Oncofene 1995 Apr 6; 10(7): 1335-41
Honors and Awards:
  • Iota Epsilon Alpha Honor Society Member, St. Gorge's University School of Medicine, 1997 - 2001
  • Dean's List, St. George's University School of Medicine, 1997 - 2001
  • Geoffery Boune Scholarship Recipient, St. George's University, School of Medicine
Selected Clinical Trials:

A Phase III, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multi-Center Trial Evaluating the Efficacy and Safety of XXX in Adult Patiets on Chronic Haemodialysis.

A Phase III, Randomized, Active-Controlled, Open-Label, Multi-Center Study of the Safety and Efficacy of XXX Injection for the Maintenance Treatment of Anemia in Hemodialysis Patients Previously Treated with Epogen.

A Phase IV, Long Term, Observational Safety Study in End Stage Renal Disease Subjects Treated with XXX.

A Phase II, Randomized Double-Blind, Placebo-Controlled, Multi-Center, to Evaluate the Safety and Efficacy of XXX in Patients with Nephropaty Due to Type 2 Diabetes.

Patient Focus Group for Qualatative Assessment of Anemia Associated with Chronic Kidney Disease.

A Multicenter, Randomized, Double-Blink Study to Evaluate the Efficacy and Safety of XXX in Patients with Type 2 Diabetes Mellitus and End Stage Renal Disease Who Are on Dialysis and Who Have Inadequate Glycemic Control.

A Phase II Study of the Safety and Efficacy of XXX Injection for the Maintenace Treatment of Anemia in Subjects with Chronic Renal Failure on Hemodialysis, of Do Not Requre Dialysis and Previously Treated with Darbepoetin Alfa.

Certificate of Completion:

The National Institutes of Heath (NIH) Office of Extramural Research Certifies that David Pai Successfully Completed the NIH Web-Based Training Course "Protecting Human Research Participants" 07-01-2009. Certification Number 250174.

Our Locations

CNMG

Capital Nephrology Medical Group

333 University Av., Suite 120

Sacramento, CA 95825

Tel: 916-929-8564

Fax: 916-929-4529



View Office Locations in a larger map

We care about your and your family members' health and helping you make wise care decisions.

Understanding what kind of care you and your family members need is important.

If you think you or your family member has a medical or psychiatric emergency, call 911 or go to the nearest hospital. Do not attempt to access emergency care through this website.